Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Feb;32(2):246-250.
doi: 10.1177/0883073816666221. Epub 2016 Sep 28.

A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder

Affiliations
Case Reports

A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder

Caterina Garone et al. J Child Neurol. 2017 Feb.

Abstract

SUCLA2 defects have been associated with mitochondrial DNA (mtDNA) depletion and the triad of hypotonia, dystonia/Leigh-like syndrome, and deafness. A 9-year-old Brazilian boy of consanguineous parents presented with psychomotor delay, deafness, myopathy, ataxia, and chorea. Despite the prominent movement disorder, brain magnetic resonance imaging (MRI) was normal while 1H-magnetic resonance spectroscopy (MRS) showed lactate peaks in the cerebral cortex and lateral ventricles. Decreased biochemical activities of mitochondrial respiratory chain enzymes containing mtDNA-encoded subunits and mtDNA depletion were observed in muscle and fibroblasts. A novel homozygous mutation in SUCLA2, the first one in the ligase coenzyme A (CoA) domain of the protein, was identified. Escalating doses of CoQ10 up to 2000 mg daily were associated with improvement of muscle weakness and stabilization of the disease course. The findings indicate the importance of screening for mitochondrial dysfunction in patients with complex movement disorders without brain MRI lesions and further investigation for potential secondary CoQ10 deficiency in patients with SUCLA2 mutations.

Keywords: SUCLA2; brain MRI; coenzyme Q10; movement disorders.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF CONFLICTING INTERESTS

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1:
Figure 1:
Panel A-C: Axial, sagittal and coronal T2-weighted brain MRI images showing normal gray and white matter; Panel D: spectral metabolites of brain MRS showing lactate peak. Panel E-H: cytochrome c oxidase (COX) (E), modified Gomori trichrome (F), oil-red-oil (G) and hematoxylin and eosin (H) stains of muscle biopsy showing lipid droplets and ragged fibers.

Similar articles

Cited by

References

    1. Hirano M, Marti R, Ferreiro-Barros C, et al. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin Cell Develop Biol. 2001;12(6): 417–27. - PubMed
    1. Kornblum C, Nicholls TJ, Haack TB, et al. Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease. Nature genetics. 2013;45(2): 214–9. - PMC - PubMed
    1. Copeland WC. Defect in mitochondrial DNA replication and human disease. Critical Review in Biochemistry and Molecular Biology. 2012;47(1): 64–74. - PMC - PubMed
    1. Miller C, Wang L, Ostergaard E, Dan P and Saada A. The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion. Biochimica et biophysica acta. 2011;1812(5): 625–9. - PubMed
    1. Elpeleg O, Miller C, Hershkovitz E, et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet. 2005;76(6): 1081–6. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts